Your browser doesn't support javascript.
loading
Changes in thyroid nodule cytology rates after institutional implementation of the Thyroid Imaging Reporting and Data System.
Ramonell, Kimberly M; Ohori, N Paul; Liu, Jason B; McCoy, Kelly L; Furlan, Alessandro; Tublin, Mitchell; Carty, Sally E; Yip, Linwah.
Afiliación
  • Ramonell KM; Division of Endocrine Surgery, Department of Surgery, University of Pittsburgh, Pittsburgh, PA. Electronic address: ramonellkm@upmc.edu.
  • Ohori NP; Department of Pathology, University of Pittsburgh, Pittsburgh, PA.
  • Liu JB; Division of Endocrine Surgery, Department of Surgery, University of Pittsburgh, Pittsburgh, PA.
  • McCoy KL; Division of Endocrine Surgery, Department of Surgery, University of Pittsburgh, Pittsburgh, PA.
  • Furlan A; Department of Radiology, University of Pittsburgh, Pittsburgh, PA.
  • Tublin M; Department of Radiology, University of Pittsburgh, Pittsburgh, PA.
  • Carty SE; Division of Endocrine Surgery, Department of Surgery, University of Pittsburgh, Pittsburgh, PA.
  • Yip L; Division of Endocrine Surgery, Department of Surgery, University of Pittsburgh, Pittsburgh, PA.
Surgery ; 173(1): 232-238, 2023 Jan.
Article en En | MEDLINE | ID: mdl-36244809
BACKGROUND: The American College of Radiology Thyroid Imaging Reporting and Data System for ultrasound classification of malignancy risk was developed to better triage thyroid nodules for fine-needle aspiration biopsy. To examine further, we compared thyroid cytologic classification rates in nodules before and after institutional Thyroid Imaging Reporting and Data System implementation. METHODS: Cytology diagnoses by Bethesda criteria (categories I-VI) from January 2014 to October 2021 were retrieved; observed changes in yearly category frequency were analyzed by linear regression; and pooled cohorts of pre- (2014-2018) and post-Thyroid Imaging Reporting and Data System (2019-2021) cytology call rates were compared. RESULTS: Overall, 7,413 cytologic specimens were included (range/year 715-1,444). From 2014 to 2021, the proportion of benign (Bethesda category II) diagnosis per year declined stepwise from 49.7% to 19.4%, and atypia of undetermined significance/follicular lesion of undetermined significance (Bethesda category III) increased sequentially from 21.3% to 51.5%. Between 2014 and 2021, Bethesda category III diagnosis increased on average by 4.8% per year (95% confidence internal, 3.29-5.54; P < .001) and Bethesda category II results decreased on average by 4.4% per year (95% confidence interval, 6.29-3.42; P < .001). When comparing pre- and post-Thyroid Imaging Reporting and Data System, the proportion of Bethesda category II cytology results decreased (43.1% vs 21%; P = .001) while Bethesda category III (28.3% vs 47.7%; P = .002) and Bethesda category V (1.1% vs 1.7%; P = .015) results increased. CONCLUSION: After implementation of American College of Radiology Thyroid Imaging Reporting and Data System ultrasound criteria, we observed a 2.5-fold decline in the rate of benign cytology and an increase in the proportion of atypia of undetermined significance/follicular lesion of undetermined significance results.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Nódulo Tiroideo Idioma: En Revista: Surgery Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Nódulo Tiroideo Idioma: En Revista: Surgery Año: 2023 Tipo del documento: Article